MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
about
Melatonin Suppresses Neuropathic Pain via MT2-Dependent and -Independent Pathways in Dorsal Root Ganglia Neurons of MiceIdentifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients.Protein interaction mapping interpretation of none alcoholic fatty liver disease model of rats after fat diet feeding.Genetic studies of human neuropathic pain conditions: a review.
P2860
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@ast
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@en
type
label
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@ast
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@en
prefLabel
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@ast
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@en
P2093
P2860
P1433
P1476
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
@en
P2093
Cielito C Reyes-Gibby
Mary Rose T Silvas
Sai-Ching J Yeung
Sanjay Shete
P2860
P2888
P356
10.1186/S12863-016-0348-7
P577
2016-02-13T00:00:00Z
P5875
P6179
1006186468